New cancer clinical trial: Study of AM0010 With Nivolumab Compared to Nivolumab Alone First-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer

Published on: December 25, 2017 at 10:00AM
Condition:   Non Small Cell Lung Cancer
Interventions:   Biological: AM0010;   Drug: Nivolumab
Sponsor:   ARMO BioSciences
Not yet recruiting
http://ift.tt/2pDnEsh